During the 2018 Winter Olympic Games, COR player #4 (Un Hyang Kim), was found to have committed an anti-doping rule violation for the unintentional consumption of hydrochlorothiazide (“HCTZ”), a S.5 prohibited diuretic/masking agent. Consequently, the Court of Arbitration for Sport did not impose an ineligibility period on the Player, and she was allowed to continue to compete in the Games.
In accordance with IOC Anti-Doping Rules applicable to the Olympic Winter Games PyeongChang 2018, the International Ice Hockey Federation has results management authority for consequences which extend beyond the Games.
As a result of the extremely low concentration found in the Player’s out-of-competition sample taken during the Olympic Games period (3 ng/ml; 197 ng/ml below WADA’s mandated detection limit of 200 ng/ml) and a subsequent negative in-competition sample taken during the Olympic Games period; after extensive research and leading experts in the field of doping indicating that the positive sample was a result of contamination; and due to the Player establishing to the comfortable satisfaction of the IIHF that the HTCZ found in her Sample was the result of contaminated food products, the IIHF offered the Player a Settlement Agreement for No Fault or Negligence.
The IIHF strongly believes that the concentration level of HTCZ found in the Player’s sample should not have been an Adverse Analytical Finding and will now work with WADA to address decision limits for certain substances that have a high probability of contamination.